Influence of folate on arterial permeability and stiffness in the absence or presence of hyperhomocysteinemia

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 26, Issue 4, 2006, Pages 814-818

  Symons, J David ^a,d   Zaid, Ussama B ^b   Athanassious, Christian N ^b   Mullick, Adam E ^b   Lentz, Steven R ^c   Rutledge, John C ^b  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Aorta; Cardiovascular risk factors; Carotid artery; Cystathionine synthase; Mice

Indexed keywords

CYSTATHIONINE BETA SYNTHASE; DEXTRAN; FOLIC ACID; HOMOCYSTEINE;

AGING; ANIMAL MODEL; AORTA; ARTERIAL DYSFUNCTION; ARTERY COMPLIANCE; ARTERY DISEASE; ARTERY PERMEABILITY; ARTERY STIFFNESS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; CONTROLLED STUDY; DISEASE SEVERITY; ELASTOGRAPHY; ENZYME DEFICIENCY; FLUORESCENCE MICROSCOPY; FOLIC ACID DEFICIENCY; HYPERHOMOCYSTEINEMIA; LIVER LEVEL; MOUSE; NONHUMAN; PHYSICAL STRESS; PRIORITY JOURNAL;

ANIMALS; CAPILLARY PERMEABILITY; CAROTID ARTERIES; CYSTATHIONINE BETA-SYNTHASE; ENDOTHELIUM, VASCULAR; FOLIC ACID; HUMANS; HYPERHOMOCYSTEINEMIA; MICE; VASOCONSTRICTION;

EID: 33646676022     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000204408.01416.16     Document Type: Article

References (47)

1. Lentz S. Homocysteine and vascular dysfunction. Life Sciences. 1997;61:1205-1215.
2. Evans RW, Shaten BJ, Hamplel JD, Cutler JA, Kuller LH. Homocysteine and risk of cardiovascular disease in the multiple Risk Factor Intervention Trial. Arterioscler Thromb Vasc Biol. 1997;17:1947-1953.
3. Brattstrom L, Wilcken D. Homocysteine and Cardiovascular Disease: Cause or Effect? Am J Clin Nutr. 2000;72:315-323.
4. Bunout D, Petermann M, Hirsch S, De la Maza P, Suazo M, Barrera G, Kauffman R. Low serum folate but normal homocysteine levels in patients with atherosclerotic vascular disease and matched healthy controls. Nutrition. 2000;16:434-438.
5. Symons JD, Rutledge JC, Simonsen U, Pattathu RA. Vascular dysfunction produced by hyperhomocysteinemia is more severe in the presence of low-folate. Am J Physiol. 2006;290:H181-H191.
6. Stampfer MJ, Rimm EB. Folate and cardiovascular disease, why we need a trial now. JAMA. 1996;275:24:1929.
7. Verhaar M, Wever R, Kastelein J, van Dam T, Kooman HA, Rabelink TJ. 5-Methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia. Circulation. 1998;97:237-241.
8. Verhaar MC, Wever RM, Kastelein JJ, van Loon D, Milstien S, Koomans HA, Rabelink TJ. Effects of oral folic acid supplementation on endothelial function in familial hypercholestrolemia-a randomized placebo-controlled trial. Circulation. 1999;100:335-338.
9. Verhoef P, Kok F, Kruyssen D. Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 1997;17:435-441.
10. Hofmann MA, Lalla E, Lu Y, Gleason MR, Wolf BM, Tanji N, Ferran LJ Jr, Kohl B, Rao V, Kisiel W, Stern DM, Schmidt AM. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest. 2001;107:675-683.
11. Verhaar MC, Stores E, Rabelink TJ. Folates and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2002;22:6-13.
12. Symons JD, Mullick AE, Ensunsa JL, Ma AA, Rutledge JC. Hyperhomocysteinemia evoked by folate-depletion: Effects on coronary and carotid arterial function. Arterioscler Thromb Vasc Biol. 2002;22:772-780.
13. Finkelstein JD. The metabolism of homocysteine-pathways and regulation. Eur J Pediatr. 1998;157:S40-S44.
14. Watanabe M, Osada J, Aratani Y, Kluckman K, Reddick R, Malinow MR, Maeda N. Mice deficient in cystathionine β-synthase: Animal models for mild and severe homocysteinemia. Proc Natl Acad Sci U S A. 1995;92:1585-1589.
15. Miller J, Nadeau M, Smith J, Smith D, Selhub J. Folate-deficiency-induced homocysteinaemia in rats: Disruption of S-adenosylmethionine's coordinate regulation of homocysteine metabolism. Biochem J. 1994;298:415-419.
16. Nielsen LB. Transfer of low density lipoprotein into the arterial wall and risk of atherosclerosis. Atherosclerosis. 1996;123:1-15.
17. Bruel A, Oxlund H. Changes in biomechanical properties, composition of collagen and elastin, and advanced glycation endproducts of the rat aorta in relation to age. Atherosclerosis. 1996;127:155-165.
18. Gilfix BM, Blank DW, Rosenblatt DS. Novel reductant for determination of total plasma homocysteine. Clin Chem. 1997;42:687-688.
19. Mudd SH, Finkelstein JD, Refsum H, Ueland PM, Malinow MR, Lentz SR, Jacobsen DW, Brattstrom L, Wilcken B, Wilcken DEL, Blom HJ, Stabler SP, Allen RH, Selhub J, Rosenberg IH. Homocysteine and its disulfide derivatives: a suggested consensus terminology. Arterioscler Thromb Vasc Biol. 2000;20:1704-1710.
20. Tamura T. Microbiological assay of folates. Folic Acid Metabolism in Health and Disease. New York: Wiley-Liss; 1990:121-188.
21. Giles WH, Kittner SJ, Croft JB, Anda RF, Casper ML, Ford ES. Serum folate and risk for coronary heart disease: results from a cohort of US Adults. Ann Epidemiol. 1998;8:490-496.
22. Ford ES, Byers TE, Giles WH. Serum folate and chronic disease risk: findings from a cohort of United States adults. Int J Epidemiol. 1998;27:592-598.
23. Gardner GG, Banka CL, Roberts KA, Mullick AE, Rutledge JC. Modified LDL-mediated increases in endothelial layer permeability are attenuated with 17-b-estradiol. Arterioscler Thromb Vasc Biol. 1999;19:854-861.
24. Walsh BA, Mullick AE, Walzem RL, Rutledge JC. 17β-Estradiol reduces tumor necrosis factor-a-mediated LDL accumulation in the artery wall. J Lipid Res. 1999;40:387-396.
25. Mullick AE, McDonald JM, Melkonian G, Talbot P, Pinkerton KE, Rutledge JC. Reactive carbonyls from tobacco smoke increase arterial endothelial layer injury. Am J Physiol. 2002;283:H591-H597.
26. Mullick AE, Walsh BA, Reiser KM, Ruteledge J. Chronic estradiol treatment attenuates vascular stiffening, glycoxidation, and permeability in rat carotid arteries. Am J Physiol. 1998;281:H2204-H2210.
27. Walsh BA, Mullick AE, Banka CE, Rutledge JC. 17-beta estradiol acts separately on the LDL particle and artery wall to reduce LDL accumulation. J Lipid Res. 2001;41:134-141.
28. Mullick AE, Deckelbaum RJ, Goldberg IJ, Al-Haideri M, Rutledge JC. Apolipoprotein E and lipoprotein lipase increase triglyceride-rich particle binding but decrease particle penetration in arterial wall. Arterioscler Thromb Vasc Biol. 2002;22:2080-2085.
29. Sims TJ, Rasmussen LM, Oxlund H, Bailey AJ. The role of glycation cross-links in diabetic vascular stiffening. Diabetologia. 1996;39:946-951.
30. Tham DM, Martin-McNulty B, Wang Y-X, Da Cunha V, Wilson DW, Athanassious CN, Powers AF, Sullivan ME, Rutledge JC. Angiotensin II injures arterial wall causing increased aortic stiffening in apolipoprotein E-deficient mice. Am J Physiol. 2002;283:R1442-R1449.
31. Oxlund H, Rasmussen LM, Andreassen TT, Heickendorff L. Increased aortic stiffness in patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1989;32:748-752.
32. Chanarin I, Metz J. Diagnosis of cobalamin deficiency: the old and the new. Br J Haematol. 1997;97:695-700.
33. Lokk J. News and views on folate and elderly persons. J Gerontology. 2003;58:354-361.
34. Haller J. The vitamin status and its adequacy in the elderly: an international overview. Int J Vitamin Nutr Res. 1999;69:1916-1919.
35. Navab M, Berliner JA, Watson AD, Hama SY, Territo MC, Lusis AJ, Shih DM, Van Lenten BJ, Frank JS, Demer LL, Edwards PA, Fogelman AM. The yin and yang of oxidation in the development of the fatty streak. Arterioscler Thromb Vasc Biol. 1996;16:831-842.
36. Chambers JC, Ueland PM, Obeid OA, Wrigley J, Refsum H, Kooner JS. Improved vascular endothelial function after oral B vitamins: an effect mediated through reduced concentrations of free plasma homocysteine. Circulation. 2000;102:2479-2483.
37. Doshi SN, McDowell IFW, Moat SJ, Lang D, Newcombe RG, Kreden MB, Lewis MJ, Goodfellow J. Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide? Arterioscler Thromb Vasc Biol. 2001;21:1196-1206.
38. Title LM, Cummings PM, Giddens K, Benest JJ, Nassar BM. Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease. J Am Coll Cardiol. 2000;36:758-765.
39. Wilmink HW, Stores ES, Erkelens WD GW, Wever R, Banga JD, Rabelink TJ. Influence of folic acid on postprandial endothelial dysfunction. Arterioscler Thromb Vasc Biol. 2000;20:185-188.
40. Stroes ESG, van Faassen E, Yo M, Martasek P, Boer P, Govers R, Rabelink TJ. Folic acid reverts dysfunction of endothelial nitric oxide synthase. Circ Res. 2000;86:1129-1134.
41. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236-1241.
42. Kass DA, Saeki A, Tunin RS, Recchia FA. Adverse influence of systemic vascular stiffening on cardiac dysfunction and adaption to acute coronary occlusion. Circulation. 1996;93:1533-1541.
43. van Guldener C, Lambert J, ter Wee PM, Donker AJM, Stehouwer CDA. Carotid artery stiffness in patients with end-stage renal disease: no effect of long-term homocysteine-lowering therapy. Clin Nephrol. 2000;53:33-41.
44. van Dijk R, Rauwerda J, Steyn M, Twisk J, Stehouwer C. Long-term homocysteine-lowering treatment with folic acid plus pyridoxine is associated with decreased blood pressure but not with improved brachial artery endothelium-dependent vasodilation or carotid artery stiffness. Arterioscler Thromb Vasc Biol. 2001;21:2072-2079.
45. Williams C, Kingwell BA, Burke K, McPherson J, Dart AM. Folic acid supplementation for 3 weeks reduces pulse pressure and large artery stiffness independent of MTHFR genotype. Am J Clin Nutr. 2005;82:26-31.
46. Wolffenbuttel BH, Boulanger CM, Crijns FR, Huijberts MS, Poitevin P, Swennen GN, Vasan S, Egan JJ, Ulrich P. Breakers of advanced glycation end products restore large artery properties in experimental diabetes. Proc Natl Acad Sci U S A. 1998;95:4630-4634.
47. Hickling S, Hung J, Knuiman M, Jamrozik K, McQuillan B, Beilby J, Thompson P. Impact of voluntary folate fortification on plasma homocysteine and serum folate in Australia from 1995 to 2001: a population based cohort study. J Epidemiol Commun Health. 2005;59:371-376.